Loading clinical trials...
Loading clinical trials...
This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Duke University
Collaborators
NCT07220109 · Respiratory Syncytial Virus Infections
NCT07092865 · Respiratory Syncytial Virus Infections
NCT06402318 · COVID-19, SARS CoV 2 Virus, and more
NCT07239583 · Respiratory Syncytial Virus Infection, Respiratory Syncytial Virus Infections
NCT05562505 · Mechanical Ventilation Complication, Hypoxemia, and more
Duke University
Durham, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions